Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion type Assertion NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_head.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion description "[Five years after diagnosis, only 4.8% (95% CI, 0.6% to 8.8%) of patients with high densities of CD8(+) plus CD45RO(+) cells had tumor recurrence, and 86.2% (CI, 79.4% to 93.6%) survived.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_provenance.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion evidence source_evidence_literature NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_provenance.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion SIO_000772 19858404 NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_provenance.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion wasDerivedFrom befree-20140225 NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_provenance.
- NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_assertion wasGeneratedBy ECO_0000203 NP334678.RACRov76PsvsOacRzveI4cVLhY_en9AEhAw3FA_v6GF10130_provenance.